Joost P.H. Drenth

Nucleotide-binding oligomerization domain-2 modulates specific TLR pathways for the induction of cytokine release.

The inflammasome--a linebacker of innate defense.

Gastroparesis in patients with inactive Crohn's disease: a case series.

Divergent roles of SPINK1 and PRSS2 variants in tropical calcific pancreatitis.

Tropical calcific pancreatitis and its association with CTRC and SPINK1 (p.N34S) variants.

High enzyme activity UGT1A1 or low activity UGT1A8 and UGT2B4 genotypes increase esophageal cancer risk.

EPHX1 polymorphisms do not modify esophageal carcinoma susceptibility in Dutch Caucasians.

Elective switching from infliximab to adalimumab in stable Crohn's disease.

Whole-exome sequencing reveals LRP5 mutations and canonical Wnt signaling associated with hepatic cystogenesis.

Viral hepatitis C therapy: pharmacokinetic and pharmacodynamic considerations.

Aminoadamantanes for chronic hepatitis C.

Polycystic liver disease: an overview of pathogenesis, clinical manifestations and management.

Aminoadamantanes versus other antiviral drugs for chronic hepatitis C.

Diagnostic criteria in renal and hepatic cyst infection.

A new noninvasive technique for estimating hepatic triglyceride: will liver biopsy become redundant in diagnosing non-alcoholic fatty liver disease?

A stepwise approach for effective management of chronic pain in autosomal-dominant polycystic kidney disease.

Hepatic cyst infection following aspiration sclerotherapy: a case series.

The ARRIBA concept: adequate resorption of ribavirin.

Aspiration sclerotherapy combined with pasireotide to improve reduction of large symptomatic hepatic cysts (SCLEROCYST): study protocol for a randomized controlled trial.

Value of EGD in patients referred for cholecystectomy: a systematic review and meta-analysis.

LRP5 variants may contribute to ADPKD.

Lower Ribavirin Plasma Concentrations in HCV/HIV-Coinfected Patients Than in HCV-Monoinfected Patients Despite Similar Dosage.

Low prevalence of serrated polyposis syndrome in screening populations: a systematic review.

Estimation of total kidney volume in autosomal dominant polycystic kidney disease.

Severe Polycystic Liver Disease Is Not Caused by Large Deletions of the PRKCSH Gene.

Risk factors for progressive polycystic liver disease: where do we stand?

TMEM199 Deficiency Is a Disorder of Golgi Homeostasis Characterized by Elevated Aminotransferases, Alkaline Phosphatase, and Cholesterol and Abnormal Glycosylation.

CCDC115 Deficiency Causes a Disorder of Golgi Homeostasis with Abnormal Protein Glycosylation.

Management of renal cyst infection in patients with autosomal dominant polycystic kidney disease: a systematic review.

Pharmacokinetics, Efficacy, and Safety of Hepatitis C Virus Drugs in Patients with Liver and/or Renal Impairment.

Sixty milligram daclatasvir is the right dose for hepatitis C virus treatment in combination with etravirine and darunavir/ritonavir.

Systematic review with meta-analysis: Dietary adherence influences normalization of health-related quality of life in coeliac disease.

Predictors of treatment response following aspiration sclerotherapy of hepatic cysts: an international pooled analysis of individual patient data.

Ursodeoxycholic acid in advanced polycystic liver disease: A phase 2 multicenter randomized controlled trial.

High Risk of Infection During Triple Therapy with First-Generation Protease Inhibitors: A Nationwide Cohort Study.

Chromosomal abnormalities in hepatic cysts point to novel polycystic liver disease genes.

Limited Generalizability of Registration Trials in Hepatitis C: A Nationwide Cohort Study.

Building pancreatic organoids to aid drug development.

Altered Pharmacokinetics of Statins Explain Increased Risk of Rhabdomyolysis in Advanced Cirrhosis.

Center is an important indicator for choice of invasive therapy in polycystic liver disease.

Evaluating the safety and dosing of drugs in patients with liver cirrhosis by literature review and expert opinion.

Efficacy and Safety of Aspiration Sclerotherapy of Simple Hepatic Cysts: A Systematic Review.

Identification of the Best Direct-Acting Antiviral Regimen for Patients With Hepatitis C Virus Genotype 3 Infection: A Systematic Review and Network Meta-analysis.

Common single nucleotide polymorphisms in transient receptor potential melastatin type 6 increase the risk for proton pump inhibitor-induced hypomagnesemia: a case-control study.

Treatment Targets in Inflammatory Bowel Disease: Current Status in Daily Practice.

Hepatic Cyst Infection During Use of the Somatostatin Analog Lanreotide in Autosomal Dominant Polycystic Kidney Disease: An Interim Analysis of the Randomized Open-Label Multicenter DIPAK-1 Study.

The gap between registration trials and real world in hepatitis C is closing.

Aggressive Hydration for the Prevention of Post-ERCP Pancreatitis: Effective When Combined With Rectal NSAIDs?

Metformin and daclatasvir: absence of a pharmacokinetic-pharmacodynamic drug interaction in healthy volunteers.

The effect of disease severity markers on quality of life in autosomal dominant polycystic kidney disease: a systematic review, meta-analysis and meta-regression.

Decreased health-related quality of life in angiodysplasia patients: A cross-sectional cohort.

Long-Term Clinical Outcomes After Switching from Remicade to Biosimilar CT-P13 in Inflammatory Bowel Disease.

The Association of Combined Total Kidney and Liver Volume with Pain and Gastrointestinal Symptoms in Patients with Later Stage Autosomal Dominant Polycystic Kidney Disease.

Liver cyst gene knockout in cholangiocytes inhibits cilium formation and Wnt signaling.

Urinalysis of MMX-mesalazine as a tool to monitor 5-ASA adherence in daily IBD practice.

Persistent abdominal pain after laparoscopic cholecystectomy is associated with increased healthcare consumption and sick leave.

A novel in-hospital meal service improves protein and energy intake.

Clinical management of polycystic liver disease.

Assessment of Histological Remission in Ulcerative Colitis: Discrepancies Between Daily Practice and Expert Opinion.

Evidence-Based Recommendations to Improve the Safe Use of Drugs in Patients with Liver Cirrhosis.

NAFLD Phenotype in Patients With V-ATPase Proton Pump Assembly Defects.

Safe use of proton pump inhibitors in patients with cirrhosis.

The Accuracy of Pancreatic Perfusion Computed Tomography and Angiography in Predicting Necrotizing Pancreatitis: A Systematic Review.

Drug Survival and Immunogenicity After Switching From Remicade to Biosimilar CT-P13 in Inflammatory Bowel Disease Patients: Two-year Follow-up of a Prospective Observational Cohort Study.

Biochemical efficacy of tioguanine in autoimmune hepatitis: a retrospective review of practice in the Netherlands.

Adverse Events of the Duodenal-Jejunal Bypass Liner: a Systematic Review.

Severity in polycystic liver disease is associated with aetiology and female gender: Results of the International PLD Registry.

Low yield for routine laboratory checks in follow-up of coeliac disease.

Increased Mortality Among Patients With vs Without Cirrhosis and Autoimmune Hepatitis.

Drug holiday in patients with polycystic liver disease treated with somatostatin analogues.

Prevalence of Drug Prescriptions and Potential Safety in Patients with Cirrhosis: A Retrospective Real-World Study.

The association between obesity and outcomes in acute pancreatitis: an individual patient data meta-analysis.

Effect of Lanreotide on Kidney Function in Patients With Autosomal Dominant Polycystic Kidney Disease: The DIPAK 1 Randomized Clinical Trial.

Association Between Black Race and Presentation and Liver-Related Outcomes of Patients With Autoimmune Hepatitis.

Successful HCV treatment of patients on contraindicated anti-epileptic drugs: Role of drug level monitoring.

Symptom relief and not cyst reduction determines treatment success in aspiration sclerotherapy of hepatic cysts.

Risk factors for incidentally detected and symptomatic angiodysplasias: a case-control study with the general population as reference.

Predniso(lo)ne Dosage and Chance of Remission in Patients With Autoimmune Hepatitis.

Prevention of overuse: A view on upper gastrointestinal endoscopy.

Carbamazepine intervention in a patient with efavirenz-induced liver injury.

Lanreotide Reduces Liver Growth In Patients With Autosomal Dominant Polycystic Liver and Kidney Disease.

How to best measure quality of life in coeliac disease? A validation and comparison of disease-specific and generic quality of life measures.

Homozygous NMNAT2 mutation in sisters with polyneuropathy and erythromelalgia.

Surveillance endoscopy after ureterosigmoidostomy.